2 compelling ASX shares rated as buys by brokers

The 2 ASX shares in this article, including Goodman (ASX:GMG) have been rated as buys by brokers and they look like compelling stocks to own.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a number of compelling ASX shares that multiple brokers have rated as a buy and they could be worth following.

If more than one broker thinks that a business is a buy then that suggests there could be an opportunity. A single broker might be wrong. Though, of course, they could be all wrong at the same time.

With that in mind, these are two that are highly rated:

Green keyboard button saying buy stock

Image Source: Getty Images

Lovisa Holdings Ltd (ASX: LOV)

Lovisa is rated as a buy by at least three brokers including Macquarie Group Ltd (ASX: MQG). The price target for Lovisa is $15.50.

The broker thinks that Lovisa is a quality business and is a reopening trade idea. The recent FY21 half-year result was better than the broker was expecting. The Lovisa share price jumped after the half year result release.

Lovisa reported that revenue declined 9.8% to $146.9 million. Gross profit dropped 11.7% to $113.4 million. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) dropped 15.2% to $39.6 million and underlying net profit after tax (NPAT) fell 22.6% to $21.5 million.

Comparable store sales were positive in the second quarter of FY21, but down 4.5% for the half. Despite all of the COVID-19 impacts, 25 net new stores were opened by the ASX share during the half year.

Digital sales are a small part of the business, but it's generating strong growth with a rise of 335% for the half year period.

The Beeline acquisition is an important part of medium-term growth. It's expecting to convert and open for trade around 90 stores. It will be immediately cashflow positive and gives the business a base to accelerate its growth in Europe, taking the store network to over 150 stores.

In the first seven weeks of the second half of FY21 it saw comparable store sales growth of 12%.

Goodman Group (ASX: GMG)

Goodman is another ASX share that's rated as a buy by at least six brokers. One of those brokers that likes the real estate business is Citi, which has a price target of $21.

Citi likes that Goodman is benefiting from the industrial property theme. COVID-19 has been a multiplier for this effect. Lower interest rates have also helped the Goodman net tangible asset (NTA) value as well as its assets under management (AUM).

Goodman has noted that the logistics and warehousing sector are playing a significant role globally in providing essential infrastructure to the digital economy. It's expecting more demand from customers as they meet higher customer requirements and higher utilisation of properties.

In the FY21 half-year result, the global real estate ASX share saw operating earnings per share (EPS) rise by 15% to 33.1 cents. The NTA rose 3.3% over six months to $6.03, total AUM grew 5% to $51.8 billion and external AUM rose 6% to $48.5 billion.

Goodman's rental property portfolio remains strong. Occupancy was 97.9% and like for like net property income (NPI) rose by 3%. It is currently leasing 1.9 million sqm equating to $269 million of annual rental property income across the group and partnerships.

The pipeline of projects remains strong, with a development work in progress (WIP) of $8.4 billion across 56 projects in 12 countries. The yield on cost for these projects is 6.6%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »

An oil refinery worker stands in front of an oil rig with his arms crossed and a smile on his face.
Energy Shares

4 ASX 200 energy shares rated buys

ASX 200 energy shares have skyrocketed 14% over the past month.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Buy, hold, sell: BHP, CBA, and Pro Medicus shares

Are analysts bullish on the big names? Let's find out.

Read more »